Joyce Wu
Neurodevelopmental Disabilities · Los Angeles, CANPI 1831295138
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Greenwich Biosciences, Inc. at 39.6% of the total. Reporting peaked in 2019 at $9,672 and has fallen 99.0% since, to $96 in 2025. Among neurodevelopmental disabilities clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $342.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Greenwich Biosciences, Inc.$9K
- Immedica Pharma US, Inc.$5K
- Novartis$3K
- Biocodex, Inc.$3K
- Neuropace, Inc.$1K
- Zimmer Biomet$1K
- plus $1K from 6 others
Across 26 payments — averaging $11,225 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GW Research Limited$205K
- Jazz Pharmaceuticals Inc.$59K
- Novartis$28K
What the payments were for
- Consulting fees$5,98126%
- Speaking & faculty fees$10,34845%
- Travel & lodging$3,53415%
- Food & beverage$2,99213%
- Education$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Greenwich Biosciences, Inc. | 19 | $9,079 |
| Immedica Pharma US, Inc. | 11 | $5,189 |
| Novartis | 2 | $2,743 |
| Biocodex, Inc. | 3 | $2,600 |
| Neuropace, Inc. | 8 | $1,092 |
| Zimmer Biomet | 8 | $1,030 |
| Jazz Pharmaceuticals Inc. | 9 | $683 |
| Medtronic | 1 | $178 |
| Biomarin Pharmaceutical Inc. | 2 | $163 |
| AbbVie | 1 | $123 |
| Nobelpharma America, LLC | 2 | $45 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,941 in reported general payments places this provider in the 90th percentile of 21 neurodevelopmental disabilities providers in California.
See all neurodevelopmental disabilities providers in California →
Other neurodevelopmental disabilities in Los Angeles
- William ShieldsLos Angeles$5.9M
- Raman SankarLos Angeles$1.1M
- Jason LernerLos Angeles$11K
- Christopher GizaLos Angeles$7K
- Ying PengLadera Ranch$18K
- Elysa MarcoSan Francisco$10K
- Paul ChretienSacramento$4K
- Sabrina CarterSanta Barbara$2K
- Anuja JindalSan Diego$1K
- Rebecca GarfinkleLaguna Niguel$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.